Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation

Immunology

Volumn 124, Issue 3, 2008, Pages 357-367

  Zheng, Yan ^a   Niyonsaba, François ^a   Ushio, Hiroko ^a   Ikeda, Shigaku ^a   Nagaoka, Isao ^a   Okumura, Ko ^a   Ogawa, Hideoki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Cytokine chemokine; Human defensin; Neutrophil; Psoriasin; Reactive oxygen species

Indexed keywords

ALPHA DEFENSIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PSORIASIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ESCHERICHIA COLI; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

ALPHA-DEFENSINS; APOPTOSIS; CALCIUM; CALCIUM-BINDING PROTEINS; CELL DEGRANULATION; CELLS, CULTURED; CHEMOKINES; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; NADPH OXIDASE; NEUTROPHIL ACTIVATION; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; ZINC;

EID: 44849110924     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02782.x     Document Type: Article

References (58)

1. Niyonsaba F, Nagaoka I, Ogawa H. Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit Rev Immunol 2006 26: 545 76.
2. Donato R. Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta 1999 1450: 191 231.
3. Hoffmann HJ, Olsen E, Etzerodt M, Madsen P, Thogersen HC, Kruse T, Celis JE. Psoriasin binds calcium and is upregulated by calcium to levels that resemble those observed in normal skin. J Invest Dermatol 1994 103: 370 5.
4. Madsen P, Rasmussen HH, Leffers H et al. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 1991 97: 701 12.
5. Algermissen B, Sitzmann J, LeMotte P, Czarnetzki B. Differential expression of CRABP II, psoriasin and cytokeratin 1 mRNA in human skin diseases. Arch Dermatol Res 1996 288: 426 30.
6. Moog-Lutz C, Bouillet P, Regnier CH et al. Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. Int J Cancer 1995 63: 297 303.
7. Celis JE, Rasmussen HH, Vorum H, Madsen P, Honore B, Wolf H, Orntoft TF. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol 1996 155: 2105 12.
8. Watson PH, Leygue ER, Murphy LC. Psoriasin (S100A7). Int J Biochem Cell Biol 1998 30: 567 71.
9. Ostergaard M, Wolf H, Orntoft TF, Celis JE. Psoriasin (S100A7): a putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas. Electrophoresis 1999 20: 349 54.
10. Yoshio H, Tollin M, Gudmundsson GH, Lagercrantz H, Jornvall H, Marchini G, Agerberth B. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res 2003 53: 211 6.
11. Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schröder JM. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005 6: 57 64.
12. Lee KC, Eckert RL. S100A7 (psoriasin) - mechanism of antibacterial action in wounds. J Invest Dermatol 2007 127: 945 57.
13. Foell D, Frosch M, Sorg C, Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004 344: 37 51.
14. Jinquan T, Vorum H, Larsen CD et al. Psoriasin: a novel chemotactic protein. J Invest Dermatol 1996 107: 5 10.
15. Renesto P, Mounier J, Sansonetti PJ. Induction of adherence and degranulation of polymorphonuclear leukocytes: a new expression of the invasive phenotype of Shigella flexneri. Infect Immun 1996 64: 719 23.
16. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 1983 130: 1910 7.
17. LeBel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992 5: 227 31.
18. Niyonsaba F, Ushio H, Nakano N et al. Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 2007 127: 594 604.
19. 7. J Immunol 2006 176: 3044 52.
20. Barlow PG, Li Y, Wilkinson TS et al. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J Leukoc Biol 2006 80: 509 20.
21. Niyonsaba F, Ushio H, Nagaoka I, Okumura K, Ogawa H. The human β-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J Immunol 2005 175: 1776 84.
22. Chen X, Niyonsaba F, Ushio H, Nagaoka I, Ikeda S, Okumura K, Ogawa H. Human cathelicidin LL-37 increases vascular permeability in the skin via mast cell activation, and phosphorylates MAP kinases p38 and ERK in mast cells. J Dermatol Sci 2006 43: 63 6.
23. Chen X, Niyonsaba F, Ushio H et al. Antimicrobial peptides human β-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur J Immunol 2007 37: 434 44.
24. Bowdish DM, Davidson DJ, Speert DP, Hancock RE. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol 2004 172: 3758 65.
25. Crow JP. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1997 1: 145 57.
26. Rothe G, Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J Leukoc Biol 1990 47: 440 8.
27. Ellis JA, Mayer SJ, Jones OT. The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils. Biochem J 1988 251: 887 97.
28. Li Y, Trush MA. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun 1998 253: 295 9.
29. Grum CM, Gross TJ, Mody CH, Sitrin RG. Expression of xanthine oxidase activity by murine leukocytes. J Lab Clin Med 1990 116: 211 8.
30. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and Fas ligand expression. J Exp Med 2002 195: 59 70.
31. Yomogida S, Nagaoka I, Yamashita T. Comparative studies on the extracellular release and biological activity of guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and defensins. Comp Biochem Physiol B Biochem Mol Biol 1997 116: 99 107.
32. Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985 76: 1427 35.
33. Selsted ME, Harwig SS, Ganz T, Schilling JW, Lehrer RI. Primary structures of three human neutrophil defensins. J Clin Invest 1985 76: 1436 9.
34. Selsted ME, Harwig SS. Determination of the disulfide array in the human defensin HNP-2: a covalently cyclized peptide. J Biol Chem 1989 264: 4003 7.
35. Terui T, Ozawa M, Tagami H. Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop. Exp Dermatol 2000 9: 1 10.
36. Coxon A, Tang T, Mayadas N. Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo: a role for granulocytes/macrophage colony-stimulating factor. J Exp Med 1999 190: 923 34.
37. Lloyd AR, Oppenheim JJ. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 1992 13: 169 72.
38. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995 16: 21 6.
39. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994 179: 1695 9.
40. Bliss SK, Marshall AJ, Zhang Y, Denkers EY. Human polymorphonuclear leukocytes produce IL-12, TNF-α, and the chemokines macrophage- inflammatory protein-1α and -1β in response to Toxoplasma gondii antigens. J Immunol 1999 162: 7369 75.
41. Akahoshi T, Sasahara T, Namai R, Matsui T, Watabe H, Kitasato H, Inoue M, Kondo H. Production of macrophage inflammatory protein 3α (MIP-3α) (CCL20) and MIP-3β (CCL19) by human peripheral blood neutrophils in response to microbial pathogens. Infect Immun 2003 71: 524 6.
42. Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005 2005: 273 9.
43. Pastore S, Mascia F, Mariotti F, Dattilo C, Girolomoni G. Chemokine networks in inflammatory skin diseases. Eur J Dermatol 2004 14: 203 8.
44. Ballif BA, Blenis J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 2001 12: 397 408.
45. Chang L, Karin M. Mammalian MAP kinase signaling cascades. Nature 2001 410: 37 40.
46. Lehrer RI, Ganz T, Selsted ME, Babior BM, Curnutte JT. Neutrophils and host defense. Ann Intern Med 1988 109: 127 42.
47. Babior BM, Lambeth JD, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 2002 397: 342 4.
48. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004 4: 181 9.
49. Fialkow L, Wang Y, Downey GP. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 2007 42: 153 64.
50. Wilde CG, Griffith JE, Marra NN, Snable JL, Scott RW. Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J Biol Chem 1989 264: 11200 3.
51. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003 3: 710 20.
52. Harwig SS, Park AS, Lehrer RI. Characterization of defensin precursors in mature human neutrophils. Blood 1992 79: 1532 7.
53. Date Y, Nakazato M, Shiomi K, Toshimori H, Kangawa K, Matsuo H, Matsukura S. Localization of human neutrophil peptide (HNP) and its messenger RNA in neutrophil series. Ann Hematol 1994 69: 73 7.
54. Granelli-Piperno A, Vassalli JD, Reich E. RNA and protein synthesis in human peripheral blood polymorphonuclear leukocytes. J Exp Med 1979 149: 284 9.
55. Snyderman R, Pike MC. Chemoattractant receptors on phagocytic cells. Annu Rev Immunol 1984 2: 257 81.
56. Snyderman R, Smith CD, Verghese MW. Model for leukocyte regulation by chemoattractant receptors: roles of a guanine nucleotide regulatory protein and polyphosphoinositide metabolism. J Leukoc Biol 1986 40: 785 800.
57. Schröder JM, Harder J. Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006 63: 469 86.
58. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002 347: 1151 60.